Head-To-Head Review: Revlon (REV) vs. DS Healthcare Group (DSKX)
Revlon (NYSE: REV) and DS Healthcare Group (NASDAQ:DSKX) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.
This is a breakdown of recent ratings and target prices for Revlon and DS Healthcare Group, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DS Healthcare Group||0||0||0||0||N/A|
Revlon currently has a consensus price target of $16.00, suggesting a potential downside of 25.58%. Given Revlon’s higher probable upside, equities analysts plainly believe Revlon is more favorable than DS Healthcare Group.
Insider and Institutional Ownership
14.0% of Revlon shares are owned by institutional investors. Comparatively, 8.5% of DS Healthcare Group shares are owned by institutional investors. 78.0% of Revlon shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This table compares Revlon and DS Healthcare Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DS Healthcare Group||-104.81%||N/A||-196.55%|
Earnings and Valuation
This table compares Revlon and DS Healthcare Group’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Revlon||$2.65 billion||0.43||$293.10 million||($2.20)||-9.77|
|DS Healthcare Group||N/A||N/A||N/A||($0.77)||-0.02|
Revlon has higher revenue and earnings than DS Healthcare Group. Revlon is trading at a lower price-to-earnings ratio than DS Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Revlon has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500.
Revlon beats DS Healthcare Group on 6 of the 9 factors compared between the two stocks.
Revlon, Inc. manufactures, markets and sells around the world a range of beauty and personal care products, including color cosmetics, hair color, hair care and hair treatments, as well as beauty tools, men’s grooming products, anti-perspirant deodorants, fragrances, skincare and other beauty care products. The Company operates through four segments: Consumer, which includes cosmetics, hair color and hair care, beauty tools, anti-perspirant deodorants, fragrances and skincare products; Professional, which includes a line of products sold to hair and nail salons, and professional salon distributors, including hair color, shampoos, conditioners, styling products, nail polishes and nail enhancements; Elizabeth Arden, which include Elizabeth Arden, which produces skin care, color cosmetics and fragrances under the Elizabeth Arden brand and Other, which includes the distribution of prestige, designer and celebrity fragrances, cosmetics and skincare products.
About DS Healthcare Group
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
Receive News & Ratings for Revlon Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revlon Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.